[
  {
    "id": "a056c455b2cb6a89",
    "title": "Healthy Returns: Novo Nordisk boosts the case for its upcoming obesity pill with additional data",
    "link": "https://www.cnbc.com/2025/11/12/healthy-returns-novo-nordisk-boosts-the-case-for-its-obesity-pill.html",
    "summary": "Novo Nordisk released new data to underscore its pill's safety and effectiveness, while Trump is asked whether private plans could see lower GLP-1 costs.",
    "body": null,
    "image": null,
    "pubDate": "2025-11-12T16:43:37.000Z",
    "source": {
      "name": "CNBC â€” Markets",
      "homepage": "https://www.cnbc.com/id/100003114/device/rss/rss.html"
    },
    "lang": "en",
    "category": "health",
    "region": "global"
  }
]